Background: In order to estimate utilities for cancer studies where the EQ-5D was not used, the EORTC QLQ-C30 can be used to estimate EQ-5D using existing mapping algorithms. Several mapping algorithms exist for this transformation, however, algorithms tend to lose accuracy in patients in poor health states. The aim of this study was to test all existing mapping algorithms of QLQ-C30 onto EQ-5D, in a dataset of patients with malignant pleural mesothelioma, an invariably fatal malignancy where no previous mapping estimation has been published. Methods: Health related quality of life (HRQoL) data where both the EQ-5D and QLQ-C30 were used simultaneously was obtained from the UK-based prospective observational SWAMP (South West Area Me...
Although cancer-specific Health-Related Quality of Life (HRQOL) are commonly included in randomized ...
Although cancer-specific Health-Related Quality of Life (HRQOL) are commonly included in randomized ...
Background. Clinical trials in cancer frequently include cancer-specific measures of health but not ...
markdownabstract__Background:__ In order to estimate utilities for cancer studies where the EQ-5D wa...
Objectives: To assess the external validity of mapping algorithms for predicting EQ-5D-3L utility va...
BACKGROUND: Several mapping algorithms have been published with the EORTC-QLQ-C30 for estimating EQ-...
Background: Mapping algorithms can be used to generate health state utilities when a preference-base...
BACKGROUND: Cost-effectiveness models require quality of life utilities calculated from generic pref...
BACKGROUND: Although cancer-specific Health-related Quality-of-Life measures are commonly included i...
BACKGROUND: Clinical trials in cancer frequently include cancer-specific measures of health but not ...
AIM: Over the last years several mapping or cross-walking algorithms for deriving utilities from QLQ...
Background. Clinical trials in cancer frequently include cancer-specific measures of health but not ...
BACKGROUND: Cost-effectiveness models require quality of life utilities calculated from generic pref...
Background: Cost-effectiveness models require quality of life utilities calculated from generic pref...
Although cancer-specific Health-Related Quality of Life (HRQOL) are commonly included in randomized ...
Although cancer-specific Health-Related Quality of Life (HRQOL) are commonly included in randomized ...
Although cancer-specific Health-Related Quality of Life (HRQOL) are commonly included in randomized ...
Background. Clinical trials in cancer frequently include cancer-specific measures of health but not ...
markdownabstract__Background:__ In order to estimate utilities for cancer studies where the EQ-5D wa...
Objectives: To assess the external validity of mapping algorithms for predicting EQ-5D-3L utility va...
BACKGROUND: Several mapping algorithms have been published with the EORTC-QLQ-C30 for estimating EQ-...
Background: Mapping algorithms can be used to generate health state utilities when a preference-base...
BACKGROUND: Cost-effectiveness models require quality of life utilities calculated from generic pref...
BACKGROUND: Although cancer-specific Health-related Quality-of-Life measures are commonly included i...
BACKGROUND: Clinical trials in cancer frequently include cancer-specific measures of health but not ...
AIM: Over the last years several mapping or cross-walking algorithms for deriving utilities from QLQ...
Background. Clinical trials in cancer frequently include cancer-specific measures of health but not ...
BACKGROUND: Cost-effectiveness models require quality of life utilities calculated from generic pref...
Background: Cost-effectiveness models require quality of life utilities calculated from generic pref...
Although cancer-specific Health-Related Quality of Life (HRQOL) are commonly included in randomized ...
Although cancer-specific Health-Related Quality of Life (HRQOL) are commonly included in randomized ...
Although cancer-specific Health-Related Quality of Life (HRQOL) are commonly included in randomized ...
Background. Clinical trials in cancer frequently include cancer-specific measures of health but not ...